Reveal the road ahead—establishing your treatment plan

GAMMAGARD LIQUID is administered as an intravenous (IV) infusion. That means it’s delivered into a vein. You and your doctor will talk about the plan for your care and decide what’s best for you. It’s also important to know that it’s not unusual for your plan to change as you continue treatment. This is because your doctor will make adjustments based on what’s right for you and your symptoms.

Think about how infusions will fit into your everyday routine

Icon of IVIG bag.

4 site of care options

Where would you like to receive treatment? GAMMAGARD LIQUID is given by a healthcare professional in your home, physician’s office, at a hospital, or an infusion center.

Icon of calendar.

Given 1 or 2 times per month

Most often, infusions are given every 2 to 4 weeks for MMN. Your doctor will help determine what’s right for you.

Icon of clock.

Infusion time will vary

The exact infusion time may take a few hours and will depend on the infusion rate, the dose being administered and patient tolerability. Ask your doctor how long it will take for you, so you can plan out your day.

Talk with your doctor

Remember, your doctor will only know how well your plan is working if you tell them. Want help discussing where you are now—and where you’d like to be? This doctor discussion guide can help.

Build your guide

Patient talking to his doctor.

Nick discusses his diagnosis and treatment

When I get my infusions, I like to play games on my smartphone. And sometimes, I like to catch up with the staff at the infusion center.

Nick

Real MMN patient on
GAMMAGARD LIQUID

Individual experiences may vary.

In 2008, my doctor diagnosed me with possible MMN. At that point, he was unsure if I had that or a lower motor neuron disease. But in 2010, another doctor performed an EMG test and found a conduction block, which confirmed my diagnosis of multifocal motor neuropathy.

And in 2012, I started treatment on GAMMAGARD LIQUID. My doctor told me that GAMMAGARD LIQUID is an infusion given by a healthcare professional either at home with a nurse or at an infusion center. My doctor told me that GAMMAGARD LIQUID could help increase my strength and dexterity, which would help me with everyday activities.

He said I might experience some side effects, such as flu-like symptoms. After weighing the benefits and the risks, my doctor and I decided that GAMMAGARD LIQUID would be a good option for me.

I do my infusions at the infusion center, which is about 20 minutes from my house. When I go to get infusions, I like to play games on my smart phone. And sometimes I like to catch up with the staff at the infusion center.

GAMMAGARD LIQUID treatment journey

Icon of clock with counter-clockwise pointing arrow.

Before Treatment

  • If this is your first intravenous administration, your insurance company may be contacted for prior authorization
  • Make sure you’re hydrated—drink plenty of fluids
  • Bring a book or other materials if you’d like to keep yourself occupied during the IVIG infusion
Icon of IVIG bag.

During Treatment

  • An IV catheter will be placed in the vein
  • Relax and sit comfortably
  • Inform your healthcare provider if you experience any discomfort
  • Your vital signs will be monitored to ensure that the infusion is being tolerated
Icon of clock with clockwise pointing arrow.

After Treatment

  • Report any side effects to your doctor or nurse
  • Stay hydrated—continue to drink fluids
  • Record how you are feeling between infusions in the experience tracker

The most common side effects of GAMMAGARD LIQUID for MMN include:

  • Headache
  • Nausea
  • Chest discomfort
  • Sore throat
  • Muscle spasms
  • Ear pain
  • Muscular weakness
  • Pain in hands or feet

Request a Patient Starter Kit

If your doctor has recently prescribed GAMMAGARD LIQUID for your MMN, sign up to receive a kit full of information that can help you get started.

Icon of stethoscope.

Have you discussed your
IVIG expectations with
your doctor?

Here's help
Icon of talking bubbles.

Explore MMN information and patient organizations

See resources